Merck To Develop New Drugs Despite Litigation Risks
Merck & Co. Inc. is pushing ahead with plans to develop a new cholesterol drug and a new obesity drug even though they are similar to other drugs with safety problems....To view the full article, register now.
Already a subscriber? Click here to view full article